“…The polypeptide hormone, glucagon, has been reported to possess a marked positive inotropic effect on isolated cardiac muscle (Farah and Tuttle, 1960;Glick et al, 1968;Lucchesi, 1968), in intact animals (Glick et al, 1968;Lucchesi, 1968) and in patients with impaired cardiac function (Brogan et al, 1969;Vaughn et al, 1970;Wilcken and Lvoff, 1970;Siegel et al, 1970;Lvoff and Wilcken, 1972). There is some uncertainty, however, concerning the effectiveness of glucagon in the management of patients with chronic cardiac decom-pensation (Williams et al, 1969;Greenberg et al, 1970;Smithen et al, 1972).…”